Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mangoceuticals (MGRX) Short-term Investments (2023 - 2025)

Mangoceuticals (MGRX) has disclosed Short-term Investments for 3 consecutive years, with $33899.0 as the latest value for Q4 2025.

  • Quarterly Short-term Investments rose 100.09% to $33899.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $33899.0 through Dec 2025, up 100.09% year-over-year, with the annual reading at $33899.0 for FY2025, 100.09% up from the prior year.
  • Short-term Investments hit $33899.0 in Q4 2025 for Mangoceuticals, up from $16942.0 in the prior quarter.
  • In the past five years, Short-term Investments ranged from a high of $33899.0 in Q4 2025 to a low of $16942.0 in Q4 2023.
  • Historically, Short-term Investments has averaged $19364.4 across 3 years, with a median of $16942.0 in 2023.
  • Biggest five-year swings in Short-term Investments: changed 0.0% in 2024 and later skyrocketed 100.09% in 2025.
  • Year by year, Short-term Investments stood at $16942.0 in 2023, then changed by 0.0% to $16942.0 in 2024, then surged by 100.09% to $33899.0 in 2025.
  • Business Quant data shows Short-term Investments for MGRX at $33899.0 in Q4 2025, $16942.0 in Q3 2025, and $16942.0 in Q2 2025.